Tag Archives: Pfizer

How Pfizer Profited From the Pandemic

According to Kaiser Health News (KHN),1 the COVID-19 pandemic has been a real boon to Pfizer. Not only has it yielded “outsize benefits” in terms of profits, but it has also “given the drugmaker unusual weight in determining U.S. health policy.” “Based on internal research, the company’s executives have frequently announced the next stage in… Read More »

Why Is the FDA Hiding the Pfizer Vaccine Data?

Despite the FDA’s claim that it is committed to transparency, especially for COVID-19 emergency use authorizations (EUAs),1 the agency first requested 55 years to release the data supporting the approval of Comirnaty after a Freedom of Information Act (FOIA) request was filed,2 and then asked for an extra 20 years to fully comply.3 Pfizer has… Read More »

Pfizer is not superior to Moderna and it’s ‘perfectly okay’ to mix COVID vaccines, experts say

Breadcrumb Trail Links News Health Canada While health authorities are reassuring Canadians that it’s safe to mix COVID-19 vaccines doses, some appear to be rejecting Moderna for Pfizer Author of the article: Sharon Kirkey Publishing date: Jun 24, 2021  •  4 days ago  •  5 minute read  •  126 Comments “There may be some brand recognition… Read More »

#FierceMadness pharma ad contest narrows: Pfizer, Bayer, Novartis, ViiV and Biohaven among the Elite Eight still standing

FierceMadess voters have spoken—and now, just an Elite Eight pharma advertisers are still in the running for the 2021 title.  Pfizer, Bayer, Novartis, Roche, Johnson & Johnson and GlaxoSmithKline’s ViiV Healthcare are among the Big Pharma contenders still playing in the DTC ad campaign contest, while Evofem Biosciences and Biohaven Pharmaceuticals are the smaller upstarts looking for… Read More »

Pfizer halts biosimilar programs in crowded China market, sells plant to WuXi Biologics

China only approved its first biosimilar drug in 2019, but the market is already looking too crowded for one Big Pharma company. Pfizer has halted its biosimilar programs in China and is selling a biologics facility there to Chinese CDMO giant WuXi Biologics, the company said in a statement Wednesday. The “difficult decision” came after a… Read More »